296 related articles for article (PubMed ID: 36703729)
41. Efficacy and tolerability of a single-pill combination of telmisartan/hydrochlorothiazide 80/25 mg in Chinese and Korean patients with moderate to severe hypertension: a subgroup analysis of a randomized, double-blind, active-controlled trial.
Zhu DL; Gao PJ; Liu SW; Jeong MH; Mattheus M; Birgit V
Chin Med J (Engl); 2013 Nov; 126(21):4072-7. PubMed ID: 24229676
[TBL] [Abstract][Full Text] [Related]
42. Effect of Qingxuan Granule () on blood pressure variability of hypertensive patients with and without obstructive sleep apnea.
Chen YY; Chen J; Zhang JC; Chen KJ
Chin J Integr Med; 2013 Oct; ():. PubMed ID: 24126974
[TBL] [Abstract][Full Text] [Related]
43. Intervention at lower blood pressure levels to achieve target goals in type 2 diabetes: PRADID (PResión Arterial en DIabéticos tipo Dos) study.
Ruilope LM; Usan L; Segura J; Bakris GL
J Hypertens; 2004 Jan; 22(1):217-22. PubMed ID: 15106814
[TBL] [Abstract][Full Text] [Related]
44. Blood pressure lowering efficacy of renin inhibitors for primary hypertension.
Musini VM; Lawrence KA; Fortin PM; Bassett K; Wright JM
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD007066. PubMed ID: 28379619
[TBL] [Abstract][Full Text] [Related]
45. Trough-to-peak ratio, smoothness index, and circadian blood pressure profile after treatment with once-daily fixed combination of losartan 100 and hydrochlorothiazide 25 in essential hypertension.
Coca A; Sobrino J; Soler J; Felip A; Pelegrí A; Mínguez A; Vila J; de la Sierra A; Plana J
J Cardiovasc Pharmacol; 2002 Jun; 39(6):824-33. PubMed ID: 12021576
[TBL] [Abstract][Full Text] [Related]
46. Association Between the Improvement of Knowledge, Attitude and Practice of Hypertension Prevention and Blood Pressure Control-A Cluster Randomized Controlled Study.
Hu Z; Wang X; Zheng C; Zhang L; Cao X; Tian Y; Gu R; Cai J; Tian Y; Shao L; Wang Z
Am J Health Promot; 2024 Apr; ():8901171241237016. PubMed ID: 38610124
[TBL] [Abstract][Full Text] [Related]
47. Effectiveness and Tolerability of Nifedipine GITS in Patients with Chronic Kidney Disease and Uncontrolled Hypertension: A Prospective, Multicenter, Observational Study (ADRENAL).
Lv R; Chen J; Wang H; Wang J; Cheng H; Li R; Li W; Zhang T; Wei L; Chen Q; Huang J; Yu F; Shen S; Wu H; Liu C; Hong F; Liu J; Zhang X; Xiao H; Song W
Adv Ther; 2021 Sep; 38(9):4771-4785. PubMed ID: 34331258
[TBL] [Abstract][Full Text] [Related]
48. Efficacy and tolerability of olmesartan medoxomil combined with amlodipine in patients with moderate to severe hypertension after amlodipine monotherapy: a randomized, double-blind, parallel-group, multicentre study.
Volpe M; Brommer P; Haag U; Miele C
Clin Drug Investig; 2009; 29(1):11-25. PubMed ID: 19067471
[TBL] [Abstract][Full Text] [Related]
49. Influence of age and hypertension treatment-time on ambulatory blood pressure in hypertensive patients.
Hermida RC; Ayala DE; Crespo JJ; Mojón A; Chayán L; Fontao MJ; Fernández JR
Chronobiol Int; 2013 Mar; 30(1-2):176-91. PubMed ID: 23077974
[TBL] [Abstract][Full Text] [Related]
50. ABPM comparison of the antihypertensive profiles of the selective angiotensin II receptor antagonists telmisartan and losartan in patients with mild-to-moderate hypertension.
Mallion J; Siche J; Lacourcière Y
J Hum Hypertens; 1999 Oct; 13(10):657-64. PubMed ID: 10516734
[TBL] [Abstract][Full Text] [Related]
51. Efficacy and safety of olmesartan/amlodipine/hydrochlorothiazide in patients with hypertension not at goal with mono, dual or triple drug therapy: results of the CHAMPiOn study.
Punzi HA
Ther Adv Cardiovasc Dis; 2014 Feb; 8(1):12-21. PubMed ID: 24492985
[TBL] [Abstract][Full Text] [Related]
52. [Comparative Efficacy of the Influence of Fixed Combinations of Antihypertensive Drugs That Block the Renin-Angiotensin-Aldosterone System, With Thiazide Diuretics on the Parameters of Ambulatory Blood Pressure Monitoring].
Ostroumova OD; Garelik IA
Kardiologiia; 2016 Dec; 56(12):20-26. PubMed ID: 28290800
[TBL] [Abstract][Full Text] [Related]
53. A multicenter, randomized, double-blind study of the antihypertensive efficacy and tolerability of irbesartan in patients aged > or = 65 years with mild to moderate hypertension.
Lacourcière Y
Clin Ther; 2000 Oct; 22(10):1213-24. PubMed ID: 11110232
[TBL] [Abstract][Full Text] [Related]
54. A Prospective, Randomized Open-Label Study for Assessment of Antihypertensive Effect of Telmisartan Versus Cilnidipine Using Ambulatory Blood Pressure Monitoring (START ABPM Study).
Sawant R; Suryawanshi S; Jadhav M; Barkate H; Bhushan S; Rane T
Cardiol Res; 2023 Jun; 14(3):211-220. PubMed ID: 37304922
[TBL] [Abstract][Full Text] [Related]
55. Efficacy of Allisartan Isoproxil in the Treatment of Mild-to-Moderate Essential Hypertension.
Wang H; Xi Y; Chen Y; Wang L; Yang F; Lu X; Sun N
Am J Hypertens; 2023 Sep; 36(10):561-567. PubMed ID: 37343187
[TBL] [Abstract][Full Text] [Related]
56. The effects of KT3-671, a new angiotensin II (AT 1) receptor blocker in mild to moderate hypertension.
Patterson D; Webster J; McInnes G; Brady A; MacDonald T
Br J Clin Pharmacol; 2003 Nov; 56(5):513-9. PubMed ID: 14651725
[TBL] [Abstract][Full Text] [Related]
57. Efficacy and safety of fosinopril/hydrochlorothiazide combinations on ambulatory blood pressure profiles in hypertension. Fosinopril/Hydrochlorothiazide Investigators.
Guthrie R; Reggi DR; Plesher MM; Saini RK; Battikha JP
Am J Hypertens; 1996 Apr; 9(4 Pt 1):306-11. PubMed ID: 8722432
[TBL] [Abstract][Full Text] [Related]
58. The fixed-dose combination of losartan/hydrochlorothiazide elicits potent blood pressure lowering during nighttime in obese hypertensive patients.
Ibuki C; Seino Y; Otsuka T; Mizuno K
J Clin Med Res; 2014 Feb; 6(1):8-16. PubMed ID: 24400025
[TBL] [Abstract][Full Text] [Related]
59. Efficacy and safety of naotaifang capsules for hypertensive cerebral small vessel disease: Study protocol for a multicenter, randomized, double-blind, placebo-controlled clinical trial.
Fang R; Hu H; Zhou Y; Wang S; Mei Z; She R; Peng X; Jiang Q; Wang X; Xie L; Lin H; Meng P; Zhang K; Wang W; Xie Y; Liu L; Tong J; Wu D; Luo Y; Liu C; Lu Y; Yu S; Cheng S; Xu L; Fang Z; Shang H; Ge J
Front Pharmacol; 2022; 13():967457. PubMed ID: 36686705
[No Abstract] [Full Text] [Related]
60. Blood pressure lowering efficacy of beta-1 selective beta blockers for primary hypertension.
Wong GW; Boyda HN; Wright JM
Cochrane Database Syst Rev; 2016 Mar; 3(3):CD007451. PubMed ID: 26961574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
